Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: A study of quantitative contrast echocardiography and strain rate imaging

Heart

Volumn 92, Issue 10, 2006, Pages 1414-1419

  Moir, S ^a   Hanekom, L ^a   Fang, Z Y ^a   Haluska, B ^a   Wong, C ^a   Burgess, M ^a   Marwick, Thomas H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE TEST; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; HYPERTENSION; IMAGING SYSTEM; MICROANGIOPATHY; MYOCARDIAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

CARDIOMYOPATHIES; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 33748352163     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.079350     Document Type: Article

References (26)

1. Fang ZY, Yuda S, Anderson V, et al. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol 2003;41:611-7.
2. Picano E, Lattanzi F, Masini M, et al. Usefulness of the dipyridamole-exercise echocardiography test for diagnosis of coronary artery disease. Am J Cordial 1988;62:67-70.
3. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004;25:543-67.
4. Strauer BE, Molz W, Vogt M, et al. Impaired coronary flow reserve in NIDDM: a possible role for diabetic cardiopathy in humans. Diabetes 1997;46(Suppl 2):S119-24.
5. Strauer BE, Motz W, Vogt M, et al. Evidence for reduced coronary flow reserve in patients with insulin-dependent diabetes: a possible cause for diabetic heart disease in man. Exp Clin Enodocrinol Diabetes 1997;105:15-20.
6. Yokoyama I, Momomura S, Ohtake T, et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1997;30:1472-7.
7. Pitkanen OP, Nuutila P, Raitakari OT, et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes 1998;47:248-54.
8. Nahser PJ Jr, Brown RE, Oskarsson H, et al. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995;91:635-40.
9. Fang ZY, Najos-Valencia O, Leano R, et al. Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine. J Am Coll Cardiol 2003;42:446-53.
10. Wei K, Ragosta M, Thorpe J, et al. Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardiography. Circulation 2001;103:2560-5.
11. Peltier M, Vancraeynest D, Pasquet A, et al. Assessment of the physiologic significance of coronary disease with dipyridamole real-time myocardial contrast echocardiography: comparison with technetium-99m sestamibi single-photon emission computed tomography and quantitative coronary angiography. J Am Coll Cardiol 2004;43:257-64.
12. Greenberg NL, Firstenberg MS, Castro PL, et al. Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility. Circulation 2002;105:99-105.
13. Urheim S, Edvardsen T, Torp H, et al. Myocardial strain by Doppler echocardiography: validation of a new method to quantify regional myocardial function. Circulation 2000;102:1158-64.
14. Moir S, Haluska BA, Jenkins C, et al. Incremental benefit of myocardial contrast to combined dipyridamole-exercise stress echocardiography for the assessment of coronary artery disease. Circulation 2004;110:1108-13.
15. Mark DB, Hlatky MA, Harrell FE Jr, e et al. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 1987;106:793-800.
16. Leong-Poi H, Le E, Rim SJ, et al. Quantification of myocardial perfusion and determination of coronary stenosis severity during hyperemia using real-time myocardial contrast echocardiography. J Am Soc Ecnocardiogr 2001;14:1173-82.
17. Masugata H, Lafitte S, Peters B, et al. Comparison of real-time and intermittent triggered myocardial contrast echocardiography for quantification of coronary stenosis severity and transmural perfusion gradient. Circulation 2001;104:1550-6.
18. Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998;97:473-83.
19. Sheikh KH, Bengtson JR, Helmy S, et al. Relation of quantitative coronary lesion measurements ID the development of exercise-induced ischemia assessed by exercise echocardiography. J Am Coll Cordial 1990;15:1043-51.
20. Andersen NH, Poulsen SH, Eiskjaer H, et al. Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with type II diabetes mellitus: a Doppler tissue tracking and strain rate echocardiography study. Clin Sci (Lond) 2003;105:59-66.
21. Vinereanu D, Nicolaides E, Tweddel AC, et al. Subclinical left ventricular dysfunction in asymptomatic patients with type II diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci (Lond) 2003;105:591-9.
22. Sutherland GR, Di Salvo G, Claus P, et al. Strain and strain rate imaging: a new clinical approach to quantifying regional myocardial function. J Am Soc Ecnocardiogr 2004;17:788-802.
23. Pitkanen OP, Nuutila P, Raitakari OT, et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes 1998;47:248-54.
24. Fischer VW, Barner HB, Leskiw ML. Capillary basal laminar thickness in diabetic human myocardium. Diabetes 1979;28:713-9.
25. Kawaguchi M, Techigawara M, Ishihata T, et al. A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. Heart Vessels 1997;12:267-74.
26. Hansen A, Johansson BL, Wahren J, et al. C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes 2002;51:3077-82.